Status:
UNKNOWN
L-arginine Versus Sildenafil in Children With Beta Thalassemia Associated With Pulmonary Hypertension
Lead Sponsor:
Sherief Abd-Elsalam
Conditions:
Thalassemia
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
This study compares L-arginine Versus Sildenafil as treatment for pulmonary hypertension in Children with Beta Thalassemia
Detailed Description
This study focuses on different lines of treatment for pulmonary hypertension in children with thalassemia as this study discusses the Effect of L-arginine Versus Sildenafil in Children with Beta Thal...
Eligibility Criteria
Inclusion
- Children with thalassemia and pulmonary hypertension.
Exclusion
- Rheumatic heart diseases.
- Other comorbid disease
Key Trial Info
Start Date :
July 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03402191
Start Date
July 1 2016
End Date
December 1 2023
Last Update
August 27 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sherief Abd-Elsalam
Tanta, Egypt